Cargando…
Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants
Autores principales: | McBride, Lucy, Houlihan, Christine, Quinlan, Catherine, Messazos, Betty, Stark, Zornitza, Crosthwaite, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551508/ https://www.ncbi.nlm.nih.gov/pubmed/31194112 http://dx.doi.org/10.1016/j.ekir.2019.02.018 |
Ejemplares similares
-
Infantile Nephrocalcinosis Resulting From a Pathogenic CYP24A1 Mutation
por: Murphy, Joel D., et al.
Publicado: (2019) -
Iatrogenic Hypercalcemia Postrenal Transplantation
por: Kelly, Yvelynne P., et al.
Publicado: (2018) -
Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
por: Perrin, Peggy, et al.
Publicado: (2021) -
A Pregnant Woman With Hypercalcemia-Induced Acute Pancreatitis
por: Fages, Victor, et al.
Publicado: (2023) -
Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required
por: McBride, Lucy, et al.
Publicado: (2018)